PCM
LH icon

Poehling Capital Management’s Labcorp LH Stock Holding History

Poehling Capital Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14,463
Closed -$1.57M – 116
2020
Q1 		$1.57M Buy
+14,463
New +$2.08M 1.15% 32
2019
Q2 		– Sell
-12,799
Closed -$1.68M – 106
2019
Q1 		$1.68M Sell
12,799
-66
-0.5% -$8.13K 1.23% 31
2018
Q4 		$1.4M Buy
+12,865
New +$1.72M 1.35% 22

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Poehling Capital Management's LH Position: Q2 2020 in Review

Poehling Capital Management sold out of Labcorp (LH) in Q2 2020, closing a stake of 14,463 shares — an estimated $1.57M sold.

Poehling Capital Management first reported a position in LH in Q4 2018 and held it in 3 quarters. The position peaked at $1.68M in Q1 2019. 799 funds tracked by Wall St. Rank hold LH as of Q2 2020.

  • Poehling Capital Management reported no remaining Labcorp position as of Q2 2020 after selling out during the quarter.
  • Poehling Capital Management sold 14,463 Labcorp shares in Q2 2020, an estimated $1.57M.
  • Poehling Capital Management first reported a position in Labcorp in Q4 2018 and held it in 3 quarters.
  • Poehling Capital Management's Labcorp position peaked at $1.68M in Q1 2019.
  • 799 funds tracked by Wall St. Rank held Labcorp as of Q2 2020.

Based on Poehling Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.